Form EFFECT Kezar Life Sciences,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 14, 2026 |
| Accession Number: | 0001140361-26-020547 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rena Striegel of Transition Point Business Advisors Highlights Early Warning Signs in Farm Transitions
- TECNO Introduces CAMON Slim: Ultra-Slim Art Piece in Hand with Diverse Mood Light and Practical AI
- Xilam Films Greenlights Feature Adaptation of The Wolf with Bidibul Productions, Goodfellas, ARP and Crunchyroll on Board
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
